中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
长春应用化学研究所 [64]
上海药物研究所 [52]
过程工程研究所 [18]
化学研究所 [15]
上海应用物理研究所 [15]
高能物理研究所 [11]
更多
采集方式
OAI收割 [223]
iSwitch采集 [10]
内容类型
期刊论文 [233]
发表日期
2025 [1]
2024 [3]
2023 [4]
2022 [13]
2021 [12]
2020 [13]
更多
学科主题
Materials ... [6]
Chemistry [3]
Chemistry,... [3]
Chemistry;... [2]
Engineerin... [2]
Materials ... [2]
更多
筛选
浏览/检索结果:
共233条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Stimuli-Responsive Nano Drug Delivery Systems for the Treatment of Neurological Diseases
期刊论文
OAI收割
SMALL, 2025, 页码: 21
作者:
Dai, Xi-jian
;
Li, Wen-Jia
;
Xie, Dong-Dong
;
Liu, Bi-xia
;
Gong, Lianggeng
  |  
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2025/04/01
drug release
nanomaterial
neurological diseases
stimulus-responsive nanodrug delivery system
targeted therapy
Shape Engineering of Exosomes for Endoplasmic Reticulum-Targeted Delivery and Amplified Anticancer Efficacy
期刊论文
OAI收割
NANO TODAY, 2024, 卷号: 57, 页码: 15
作者:
Liang, Li
;
Wang, Ning
;
Li, Xiang
;
Zhang, Zhuan
;
Zhu, Zhu
  |  
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2024/08/22
Exosomes
Shape
Intracellular trafficking
ER-Targeted drug delivery
Anticancer therapy
Epigenetic Reprogramming Potentiates ICAM1 Antibody Drug Conjugates in Preclinical Models of Melanoma
期刊论文
OAI收割
ADVANCED SCIENCE, 2024, 卷号: 11
作者:
Zhang, Peng
;
Tao, Changjuan
;
Lu, Ye
;
Li, Peijing
;
Wang, Xing
  |  
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2024/11/20
antibody drug conjugate
decitabine
ICAM1
melanoma
targeted therapy
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
期刊论文
OAI收割
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 卷号: 17, 期号: 1, 页码: 32
作者:
Wei, Qing
;
Li, Peijing
;
Yang, Teng
;
Zhu, Jiayu
;
Sun, Lu
  |  
收藏
  |  
浏览/下载:57/0
  |  
提交时间:2024/02/27
Antibody-drug conjugate
Solid tumor
Combination therapy
Immunotherapy
Targeted therapy
Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2023, 页码: 12
作者:
Lin, Ting-ting
;
Xiong, Wei
;
Chen, Gui-hua
;
He, Yang
;
Long, Li
  |  
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2024/01/26
osimertinib resistance
targeted drug delivery
liposomes
panobinostat
tumor-associated macrophage
combination therapy
Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 6, 页码: 2601-2612
作者:
Wang, Xiaomin
;
Xu, Jun
;
Sun, Yiming
;
Cao, Siyuwei
;
Zeng, Hanlin
  |  
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2023/10/17
HDAC inhibitors
Drug resistance
Histone methylation
Histone acetylation
Epigenetic interplay
Hedgehog pathway
ZIC1
LIFR
Combination therapy
Breast cancer
Drug-Free Biomimetic Oxygen Supply Nanovehicle Promotes Ischemia-Reperfusion Therapy in Stroke
期刊论文
OAI收割
ADVANCED FUNCTIONAL MATERIALS, 2023, 卷号: 33, 期号: 21
作者:
He, Wenxiu
;
Zhang, Xiao-Yong
;
Gong, Xiang
;
Luo, Kuankuan
;
Mao, Xuening
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2024/03/27
BBB protection
drug-free biomimetic nanovehicles
hypoxia relief
ischemia-reperfusion therapy
ischemic strokes
Induction of RIPK3/MLKL-mediated necroptosis by Erigeron breviscapus injection exhibits potent antitumor effect
期刊论文
OAI收割
FRONTIERS IN PHARMACOLOGY, 2023, 卷号: 14, 页码: 1219362
作者:
Guo,Xiuping
;
Li,Rui
;
Cui,Jinjin
;
Hu,Chujuan
;
Yu,Haoyang
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2024/05/09
Erigeron breviscapus injection
Dengzhanxixin
Erigeron breviscapus (Vant
) Hand
-Mazz
colorectal cancer
necroptosis
drug resistance
TUMOR-NECROSIS-FACTOR
COLORECTAL-CANCER
NATURAL COMPOUNDS
SCUTELLARIN
APOPTOSIS
PROLIFERATION
MACROPHAGES
MIGRATION
INVASION
THERAPY
Antitumor pharmacological research in the era of personalized medicine
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2022, 卷号: 43, 期号: 12, 页码: 3015-3020
作者:
Huang, Min
  |  
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2023/04/10
personalized medicine
anticancer drug discovery
oncogene addiction
non-oncogene addiction
combination therapy
Targeting PI3K alpha overcomes resistance to KRas(G12C) inhibitors mediated by activation of EGFR and/or IGF1R
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2022, 页码: 12
作者:
Qi, Wei-liang
;
Li, Hui-yu
;
Wang, Yi
;
Xu, Lan
;
Deng, Jie-ting
  |  
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2023/04/10
AMG510
KRas(G12C)
PI3K
drug resistance
combination therapy